REVIEW ARTICLE
Year : 2021 | Volume
: 18 | Issue : 1 | Page : 7--9
Denosumab in giant cell tumor of bone – science wins over evidence
Dominic Puthoor
Department of Orthopaedics, Amala Institute of Medical Sciences, Thrissur, Kerala, India
Correspondence Address:
Dominic Puthoor
Amala Institute of Medical Sciences, Thrissur, Kerala
India
Denosumab is a relatively new drug and is used in the treatment of giant cell tumor (GCT) of bone. There are hardly any drugs such as denosumab, indication of which changed in a short period of 10 years. The author analyses the cause of this transformation of indication of that drug in the treatment of GCT of bone, based on the scientific ground, review of the literature, and personal experience.
How to cite this article:
Puthoor D. Denosumab in giant cell tumor of bone – science wins over evidence.J Orthop Assoc South Indian States 2021;18:7-9
|
How to cite this URL:
Puthoor D. Denosumab in giant cell tumor of bone – science wins over evidence. J Orthop Assoc South Indian States [serial online] 2021 [cited 2022 May 28 ];18:7-9
Available from: https://www.joasis.org/article.asp?issn=WKMP-0157;year=2021;volume=18;issue=1;spage=7;epage=9;aulast=Puthoor;type=0 |
|
